股票/基金 实时行情 股吧

简称:东北制药 代码:000597


会计年度:2014-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合 计2,320,075,258.531,540,415,535.97779,659,722.5633.60
合计2,320,075,258.531,540,415,535.97779,659,722.5633.60
减:内部抵销数463,625,954.14510,845,846.30-47,219,892.16-10.18
其他59,477,756.0051,059,342.028,418,413.9814.15
小计2,783,701,212.672,051,261,382.27732,439,830.4026.31
医药商业712,583,068.91642,477,500.2470,105,568.679.84
医药制造2,011,640,387.761,357,724,540.01653,915,847.7532.51

会计年度:2013-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:内部抵销数1,073,972,828.18999,718,441.9374,254,386.256.91
其他105,377,603.2694,503,313.9410,874,289.3210.32
医药商业1,297,645,262.251,173,830,883.38123,814,378.879.54
医药制造3,467,950,403.462,347,653,934.621,120,296,468.8432.30

会计年度:2013-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:内部抵销数642,959,707.00628,319,036.0014,640,671.002.28
其他54,989,424.0039,204,797.0015,784,627.0028.70
医药商业622,975,022.00550,877,393.0072,097,629.0011.57
医药制造1,950,161,021.001,430,071,352.00520,089,668.0026.67

会计年度:2012-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计3,729,019,634.002,787,543,162.00941,476,473.0025.25
减:内部抵销数869,650,348.00900,140,238.00-30,489,890.00-3.51
其他93,628,142.0067,384,219.0026,243,923.0028.03
医药商业1,207,632,303.001,078,801,457.00128,830,846.0010.67
医药制造3,297,409,538.002,541,497,724.00755,911,814.0022.92

会计年度:2012-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:内部抵销数671,779,612.00673,412,796.00-1,633,183.00-0.24
其他40,350,681.0032,736,421.007,614,260.0018.87
医药商业608,326,684.00539,226,952.0069,099,731.0011.36
医药制造1,951,918,599.001,550,683,836.00401,234,763.0020.56

    4/9 转到